ICI 182,780
Tocris Bioscience, part of Bio-Techne | Catalog # 1047
Estrogen receptor antagonist
Key Product Details
Description
Estrogen receptor antagonist
Alternative Names
Fulvestrant
Product Description
ICI 182,780 is a high affinity estrogen receptor antagonist (IC50 = 0.29 nM), devoid of any partial agonism both in vitro and in vivo. ICI 182,780 is a high affinity agonist at the membrane estrogen receptor GPER. ICI 182,780 inhibits MCF-7 human breast cancer cell growth in vitro and shows antitumor activity in mice models. ICI 182,780 penetrates the blood-brain-barrier and has neuronal functional effects in vivo.Product Specifications
Molecular Weight
606.77
Formula
C32H47F5O3S
Storage
Store at RT
Purity
≥98% (HPLC)
Chemical Name
7α,17β-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol
CAS Number
129453-61-8
PubChem ID
17756771
InChI Key
VWUXBMIQPBEWFH-LQKBAPIOSA-N
SMILES
OC1=CC=C2C(C[C@@H](CCCCCCCCCS(CCCC(F)(C(F)(F)F)F)=O)C3([H])[C@@]([H])2CC[C@@]4(C)[C@@](CC[C@@H]4O)3[H])=C1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 60.68 | 100 | |
| Ethanol | 30.34 | 50 |
Preparing Stock Solutions
for ICI 182,780
The following data is based on the product molecular weight 606.77
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.65 mL | 8.24 mL | 16.48 mL |
| 5 mM | 0.33 mL | 1.65 mL | 3.30 mL |
| 10 mM | 0.16 mL | 0.82 mL | 1.65 mL |
| 50 mM | 0.03 mL | 0.16 mL | 0.33 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Alfinito ICI 182,780 penetrates brain and hypothalamic tissue and has functional effects in the brain after systemic dosing. Endocrinology 2008 PMID: 18599545
- Wakeling A potent specific pure antiestrogen with clinical potential. Cancer Res. 1991 PMID: 1855205
- Howell ICI 182,780 (FaslodexTM): Development of a novel, "pure" antiestrogen. Cancer 2000 PMID: 10951345
- Thomas Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005 PMID: 15539556
- de Cupis Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting OE and IGF-I induced proliferation of human breast cancer-derived cells. Br.J.Pharmacol. 1995 PMID: 8581274
Product Specific Notices for ICI 182,780
For research use only
Loading...
Loading...
Loading...